Description:

ODM derived from http://clinicaltrials.gov/show/NCT00404885

Link:

http://clinicaltrials.gov/show/NCT00404885

Keywords:
Versions (2) ▾
  1. 12/9/13
  2. 4/15/14
Uploaded on:

December 9, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00404885 Uveitis, Anterior

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age at least 13 Years
Documented history of non-infectious anterior, anterior and intermediate- or panuveitis
Currently uncontrolled uveitis for a minimum of 2 weeks despite use of oral and/or topical corticosteroid,or subjects who are intolerant of local corticosteroid therapy due to the development of an ocular hypertensive response or subjects for whom oral corticosteroid is contraindicated.
Grade of >= 2+ for anterior chamber cells at time of enrollment
Considered by the investigator to require corticosteroid-sparing therapy.
Subjects not planning to undergo elective ocular surgery during the study
Exclusion Criteria
Uveitis of infectious etiology
Presence of an ocular toxoplasmosis scar
An immune suppression regimen that includes an alkylating agent within the previous 90 days